Basit öğe kaydını göster

Resting Tl-201 scintigraphy in the evaluation of myocardial sarcoidosis

dc.contributor.authorChin, BB
dc.contributor.authorMUDUN, Ayşe
dc.contributor.authorCivelek, AC
dc.date.accessioned2022-02-18T09:36:00Z
dc.date.available2022-02-18T09:36:00Z
dc.date.issued1997
dc.identifier.citationChin B., Civelek A., MUDUN A., "Resting Tl-201 scintigraphy in the evaluation of myocardial sarcoidosis", CLINICAL NUCLEAR MEDICINE, cilt.22, sa.7, ss.475-478, 1997
dc.identifier.issn0363-9762
dc.identifier.otherav_4a6bf447-89fd-44d4-8fe7-5676634ff2e6
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/177530
dc.identifier.urihttps://doi.org/10.1097/00003072-199707000-00006
dc.description.abstractIn patients with sarcoidosis, myocardial involvement is common and may be fatal. With extensive disease, the primary manifestations may include conduction abnormalities and arrhythmias, which may lead to sudden death. Myocardial perfusion scintigraphy may be the most accurate method to assess extent of myocardial involvement and response to therapy.
dc.language.isoeng
dc.subjectRadiological and Ultrasound Technology
dc.subjectHealth Sciences
dc.subjectDahili Tıp Bilimleri
dc.subjectRadiology, Nuclear Medicine and Imaging
dc.subjectNükleer Tıp
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectRADYOLOJİ, NÜKLEER TIP ve MEDİKAL GÖRÜNTÜLEME
dc.titleResting Tl-201 scintigraphy in the evaluation of myocardial sarcoidosis
dc.typeMakale
dc.relation.journalCLINICAL NUCLEAR MEDICINE
dc.contributor.department, ,
dc.identifier.volume22
dc.identifier.issue7
dc.identifier.startpage475
dc.identifier.endpage478
dc.contributor.firstauthorID3371353


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster